ICPMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Author
Ústav organické chemie a biochemie AV ČR
The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) is a leading scientific institution in the Czech Republic, recognized internationally. Its primary mission is basic research in the fields of chemical biology and medicinal chemistry, organic and material oriented chemistry, chemistry of natural compounds, biochemistry and molecular biology, physical chemistry, theoretical chemistry, and analytical chemistry.
Tags
Article
Video
Science and research
Logo of LinkedIn

New Czech company linked to IOCB Prague to enter global gene therapy field

Th, 27.6.2024
| Original article from: IOCB Prague
Technology from the laboratories of IOCB Prague has been given an extraordinary opportunity to succeed in the rapidly developing segment of gene therapy.
Video placeholder
  • Photo: ÚOCHB / Tomáš Belloň: The co-founders of Adalid Sciences (from the left): František Sedlák, Petr Cígler, Klára Grantz Šašková, David Schreib.
  • Video: IOCB Prague: New Czech Company Linked to IOCB Prague to Enter Global Gene Therapy Field.

Technology from the laboratories of IOCB Prague has been given an extraordinary opportunity to succeed in the rapidly developing segment of gene therapy. The results of successful research are set to be advanced by a newly established private company called Adalid Sciences, which is being supported with a major investment from BTL Group, a leading manufacturer of medical technologies.

The story begins with the discovery of new lipid nanoparticles with a comic book name coined by Dr. Petr Cígler and Dr. Klára Grantz Šašková of IOCB Prague. Acting as a sort of imaginary courier, their XMAN is capable of safely transporting nucleic acids, either the basic building blocks of DNA or the long strands of RNA, into cells. At the same time, the potential of such a molecular transport device is constantly growing because the field of gene therapy has recently been developing at break-neck speed. Nucleic acids can be used to suppress or, conversely, replace or directly repair incorrect genetic information, making it possible to fight diseases that are difficult to treat. They also play an important role in the development of vaccines, both those targeting infectious diseases as well as oncological ones.

ÚOCHB / Tomáš Belloň: The co-founders of Adalid Sciences (from the left): František Sedlák, Petr Cígler, Klára Grantz Šašková, David Schreib.

Therefore, the new company, Adalid Sciences, has a unique opportunity to assume a permanent position in the global pharmaceutical market. This is also possible thanks to the extraordinary support provided by the IOCB environment, without which promising discoveries could hardly navigate the proverbial valley of death and have any hope of achieving commercial success. Professional support comes from the institute’s subsidiary transfer company, IOCB Tech, which helps bring promising scientific ideas to life.

“There’s something in the very DNA of our institute that inspires colleagues to not only engage in outstanding science but also to apply their results in practice. And we’ve been succeeding at this since the 1960s. Not only do Antonín Holý’s drugs have their predecessors, but they’ll hopefully also have their successors,” says IOCB director Prof. Jan Konvalinka. He continues: “I appreciate the fact that successful companies invest in modern technologies that can be beneficial to everyone. The contribution of IOCB Prague to this venture lies not only in our patent but also in our brilliant scientists. They’re truly among the best that Czech science has to offer.”

The investment that Adalid received from BTL is exceptional in the Czech milieu: a major manufacturer of medical technologies has promised to invest millions of euros. The technical director of BTL, Tomáš Drbal, explains why they decided to take this step: “BTL Group is a world leader in several medical fields, so strategic investments in related areas such as biotech and pharma are a good match for the group’s vision. The outlook for the industry and the product is especially important to us, but even more important are the people who develop it. The credibility of the scientific institution from which they come to Adalid, as well as their professional and personal qualities, played a crucial role in our decision to make the investment.”

ÚOCHB / Tomáš Belloň: The versatility of the nanoparticles lies in the fact that they can work equally well for different nucleic acids. This can significantly accelerate drug development.

Adalid is being founded by IOCB researchers Klára Šašková, who will serve as the director of the new company, and Petr Cígler. In addition, one of the founders is the physician František Sedlák. Klára Šašková explains why, in her opinion, Adalid has a chance to break through: “Our advantage is that we offer lipid nanoparticles, which have significantly better properties compared to existing ones. Furthermore, not only do our particles demonstrate higher efficiency, they’re also nontoxic and are well tolerated by organisms even after repeated administration. Now we face challenging preclinical testing and negotiations with commercial partners looking for a transport system for their therapeutic nucleic acid. The goal is to get our products into clinical trials as soon as possible and emerge as one of the major players in the global field of genetic medicine.”

ÚOCHB / Tomáš Belloň: XMAN lipid nanoparticle for easy transport of various types of therapeutic nucleic acids into cells.

The groundbreaking research was published three years ago in the scientific journal Advanced Functional Materials, with the study co-led by Petr Cígler, head of the Synthetic Nanochemistry research group at IOCB Prague, who has extensive experience in developing functional transport systems for nucleic acids. He explains: “With the XMANs, we’ve managed to design a family of molecules with exceptional chemical and biological properties. We’ve been modifying the basic structure over time to improve those properties. We now have a number of unique substances that, together with nucleic acids, are capable of forming therapeutically highly active nanoparticles.”

Gene therapy offers therapeutic options for a wide range of incurable diseases, and it is already helping many people. Examples include patients with spinal muscular atrophy, congenital visual disorders, hemophilia, or oncological diseases. Thanks to scientific advances, hope is dawning for millions of others, and not just those with rare congenital diseases. The new Czech company Adalid Sciences is poised to play a key role in this important segment of contemporary medicine.

ÚOCHB / Tomáš Belloň: New Czech company linked to IOCB Prague to enter global gene therapy field.

ÚOCHB / Tomáš Belloň: New Czech company linked to IOCB Prague to enter global gene therapy field.

Ústav organické chemie a biochemie AV ČR
 

Related content

Quantifying the Similarity of Two Coffee Bean Products by GC/MS and EDXRF

Applications
| 2024 | Shimadzu
Instrumentation
X-ray, GC/MSD, GC/MS/MS, GC/QQQ, SPME
Manufacturer
Shimadzu
Industries
Food & Agriculture

Multifaceted Evaluation of IgG Glycan Profiles Considering the Components in Glycosyltransferase Reactions

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS, LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

WATER NEEDS IN PHARMA QUALITY CONTROL

Brochures and specifications
| 2019 | ELGA LabWater
Instrumentation
Laboratory instruments
Manufacturer
ELGA LabWater
Industries
Pharma & Biopharma

Elemental Analysis in Yeast Cells and Selenium Enriched Yeast Cells by ICP-MS with Automated Micro-Flow Sample Introduction

Posters
| 2024 | Agilent Technologies (ASMS)
Instrumentation
ICP/MS, ICP/MS/MS
Manufacturer
Elemental Scientific, Agilent Technologies
Industries
Clinical Research

Screening Analysis of 24 Elemental Impurity Elements in Drugs Using ICPMS-2040/2050

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
 

Related articles


Article | Scientific article

Sugar metabolism is surprisingly conventional in cancer

Study has implications for targeting metabolism in cancer treatment.
Washington University in St. Louis
more

Article | Video

RESEARCHERS SERVE UP AN IMPROVED MODEL OF INDOOR POLLUTION PRODUCED BY COOKING

New approach could inform better public health guidelines.
Johns Hopkins University
more

Article | Video

Why urea may have been the gateway to life

Urea reacts extremely quickly under the conditions that existed when our planet was newly formed. This new insight furthers our understanding of how life on Earth might have begun.
ETH Zürich
more

Article | Video

Scientists at IOCB Prague are developing a new generation of DNA tests for a wide range of applications

A research group led by Dr. Edward Curtis has developed two new types of catalytic DNA molecules (deoxyribozymes) that can reveal the presence of target molecules through fluorescence or color.
Ústav organické chemie a biochemie AV ČR
more
 

Related content

Quantifying the Similarity of Two Coffee Bean Products by GC/MS and EDXRF

Applications
| 2024 | Shimadzu
Instrumentation
X-ray, GC/MSD, GC/MS/MS, GC/QQQ, SPME
Manufacturer
Shimadzu
Industries
Food & Agriculture

Multifaceted Evaluation of IgG Glycan Profiles Considering the Components in Glycosyltransferase Reactions

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS, LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

WATER NEEDS IN PHARMA QUALITY CONTROL

Brochures and specifications
| 2019 | ELGA LabWater
Instrumentation
Laboratory instruments
Manufacturer
ELGA LabWater
Industries
Pharma & Biopharma

Elemental Analysis in Yeast Cells and Selenium Enriched Yeast Cells by ICP-MS with Automated Micro-Flow Sample Introduction

Posters
| 2024 | Agilent Technologies (ASMS)
Instrumentation
ICP/MS, ICP/MS/MS
Manufacturer
Elemental Scientific, Agilent Technologies
Industries
Clinical Research

Screening Analysis of 24 Elemental Impurity Elements in Drugs Using ICPMS-2040/2050

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
 

Related articles


Article | Scientific article

Sugar metabolism is surprisingly conventional in cancer

Study has implications for targeting metabolism in cancer treatment.
Washington University in St. Louis
more

Article | Video

RESEARCHERS SERVE UP AN IMPROVED MODEL OF INDOOR POLLUTION PRODUCED BY COOKING

New approach could inform better public health guidelines.
Johns Hopkins University
more

Article | Video

Why urea may have been the gateway to life

Urea reacts extremely quickly under the conditions that existed when our planet was newly formed. This new insight furthers our understanding of how life on Earth might have begun.
ETH Zürich
more

Article | Video

Scientists at IOCB Prague are developing a new generation of DNA tests for a wide range of applications

A research group led by Dr. Edward Curtis has developed two new types of catalytic DNA molecules (deoxyribozymes) that can reveal the presence of target molecules through fluorescence or color.
Ústav organické chemie a biochemie AV ČR
more
 

Related content

Quantifying the Similarity of Two Coffee Bean Products by GC/MS and EDXRF

Applications
| 2024 | Shimadzu
Instrumentation
X-ray, GC/MSD, GC/MS/MS, GC/QQQ, SPME
Manufacturer
Shimadzu
Industries
Food & Agriculture

Multifaceted Evaluation of IgG Glycan Profiles Considering the Components in Glycosyltransferase Reactions

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS, LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

WATER NEEDS IN PHARMA QUALITY CONTROL

Brochures and specifications
| 2019 | ELGA LabWater
Instrumentation
Laboratory instruments
Manufacturer
ELGA LabWater
Industries
Pharma & Biopharma

Elemental Analysis in Yeast Cells and Selenium Enriched Yeast Cells by ICP-MS with Automated Micro-Flow Sample Introduction

Posters
| 2024 | Agilent Technologies (ASMS)
Instrumentation
ICP/MS, ICP/MS/MS
Manufacturer
Elemental Scientific, Agilent Technologies
Industries
Clinical Research

Screening Analysis of 24 Elemental Impurity Elements in Drugs Using ICPMS-2040/2050

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
 

Related articles


Article | Scientific article

Sugar metabolism is surprisingly conventional in cancer

Study has implications for targeting metabolism in cancer treatment.
Washington University in St. Louis
more

Article | Video

RESEARCHERS SERVE UP AN IMPROVED MODEL OF INDOOR POLLUTION PRODUCED BY COOKING

New approach could inform better public health guidelines.
Johns Hopkins University
more

Article | Video

Why urea may have been the gateway to life

Urea reacts extremely quickly under the conditions that existed when our planet was newly formed. This new insight furthers our understanding of how life on Earth might have begun.
ETH Zürich
more

Article | Video

Scientists at IOCB Prague are developing a new generation of DNA tests for a wide range of applications

A research group led by Dr. Edward Curtis has developed two new types of catalytic DNA molecules (deoxyribozymes) that can reveal the presence of target molecules through fluorescence or color.
Ústav organické chemie a biochemie AV ČR
more
 

Related content

Quantifying the Similarity of Two Coffee Bean Products by GC/MS and EDXRF

Applications
| 2024 | Shimadzu
Instrumentation
X-ray, GC/MSD, GC/MS/MS, GC/QQQ, SPME
Manufacturer
Shimadzu
Industries
Food & Agriculture

Multifaceted Evaluation of IgG Glycan Profiles Considering the Components in Glycosyltransferase Reactions

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS, LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

WATER NEEDS IN PHARMA QUALITY CONTROL

Brochures and specifications
| 2019 | ELGA LabWater
Instrumentation
Laboratory instruments
Manufacturer
ELGA LabWater
Industries
Pharma & Biopharma

Elemental Analysis in Yeast Cells and Selenium Enriched Yeast Cells by ICP-MS with Automated Micro-Flow Sample Introduction

Posters
| 2024 | Agilent Technologies (ASMS)
Instrumentation
ICP/MS, ICP/MS/MS
Manufacturer
Elemental Scientific, Agilent Technologies
Industries
Clinical Research

Screening Analysis of 24 Elemental Impurity Elements in Drugs Using ICPMS-2040/2050

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
 

Related articles


Article | Scientific article

Sugar metabolism is surprisingly conventional in cancer

Study has implications for targeting metabolism in cancer treatment.
Washington University in St. Louis
more

Article | Video

RESEARCHERS SERVE UP AN IMPROVED MODEL OF INDOOR POLLUTION PRODUCED BY COOKING

New approach could inform better public health guidelines.
Johns Hopkins University
more

Article | Video

Why urea may have been the gateway to life

Urea reacts extremely quickly under the conditions that existed when our planet was newly formed. This new insight furthers our understanding of how life on Earth might have begun.
ETH Zürich
more

Article | Video

Scientists at IOCB Prague are developing a new generation of DNA tests for a wide range of applications

A research group led by Dr. Edward Curtis has developed two new types of catalytic DNA molecules (deoxyribozymes) that can reveal the presence of target molecules through fluorescence or color.
Ústav organické chemie a biochemie AV ČR
more
Other projects
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike